Guinea Pig

Compiled by
Dr. James B. Nichols, University Veterinarian






November 18, 2001


 

LABORATORY GUINEA PIG

Cavia porcellus

Background

The wild cavy or guinea pig occurs in South America from Columbia and Venezuela southward to Brazil and northern Argentina. Guinea pigs inhabit a wide variety of habitat such as rocky regions, savannas, the edge of forests and swamps. In the wild forms the hair is fairly course and long but in the domestic guinea pigs it varies from smooth and short to smooth and long to course and short in some for-ms the hair even radiates in rosettes. Although domestic guinea pigs exhibit an extremely wide range of color, the wild forms are generally gray or brownish. Guinea pigs have stocky bodies, fairly short hind legs, short ears and lack a tail. The hind feet are long with sharp claws. Guinea pigs in the wild are burrowing animals. Sometimes they live in the abandoned burrows of other animals. They generally associate in small groups, usually 5 to 10 individuals, and are always prepared to flee at the slightest indication of danger. They are nocturnal feeders and the diet consists of various forms of vegetation. South American native Indian tribes, particularly the Incas, raised them for food since their flesh is of excellent quality. During the second world war a project conducted by the Navy investigating the palatability and nutritional value of various laboratory species for the human population determined that the Guinea Pig was the most desirable of the common species. The Guinea Pig was introduced into Europe in the 16th Century by 1 the Dutch and their use spread quickly throughout the Continent. They were known by a variety of common names: "Sea Pig," "Barbary Rabbit," or "Little Sea Pig". The name Guinea Pig has become synonymous with of "experimental subject" in the that English language.

The unique characteristics of the Guinea Pig that differ from other experimental animals include the highly developed young at birth due to the long gestation period and the udder type mammary gland. The young at birth are fully developed. Their eyes are open, they are fully haired, and completely mobile. They begin eating solid food at approximately 2 to 3 days of age and can be easily weaned at 10 days. The mammary gland consists of a two section udder, each section with a single teat. Milking machines have been easily developed to utilize this udder for milk secretion research studies. The Guinea Pig is unable to synthesize an adequate supply of vitamin C and therefore must be supplied with either a supplement or a fortified diet.

Handling techniques

Guinea Pigs are probably the easiest of all the common laboratory animals to handle and restrain. They are nervous, high-strung animals compared to other laboratory rodents and are rather noisy. These sounds consist mainly of squealing, whistling, and grunting sounds. To restrain a Guinea Pig, grasp the animal around the thoracic area from above with the thumb and forefinger right behind the front legs and lift. The other hand should be placed under the Guinea Pig's hind quarters for support. Failure to restrain and support the hind quarters may result in injury to the Guinea Pig as well as injuries to the operator from scratching. Guinea Pigs rarely if ever bite. Since they have short legs and heavy bodies they are unable to climb or jump. In some instances they are housed in open-top cages or pens because of this inability to escape. IP injection of the Guinea Pig is accomplished by restraining the animal as indicated above and injecting in one of the lower quadrants of the abdomen. Subcutaneous injection can be accomplished by lifting the loose skin of the back, particularly over the neck and shoulder, and injecting under the f o I d . The Guinea Pig may be bled by heart puncture, anterior vena cava puncture, or small samples may be obtained from the medical canthus of the eye. Repeated blood sampling utilizing these methods can be accomplished if a suitable period of two or three days between drawings is allowed. In males the lateral vein the penis may be used for IV injections.

Experimental Uses

As the common usage of the term Guinea Pig implies, this species is widely employed as a research animal. The Guinea Pig has been used in antibody production, tumorigenesis, nutrition, genetics, radiation research, and dental studies including antibacterial action of saliva and production. The Guinea Pig is used extensively in laboratory studies of disease, nutrition and heredity, and in, development of sera. The Guinea Pig has been widely employed in biomedical research since 1780. Lavoisier used the cavy for measuring heat production. Much of the work relating to the discovery of Vitamin C, the diagnosis of tuberculosis, and the research on anaphylaxis has been performed in this species.

Strains and Sources

The majority of Guinea Pigs used in this country are random bred Guinea Pigs. Although inbreeding of Guinea Pigs was initiated at the Bureau of Animal Industry facility near Washington, D.C., in 1897, only two inbred strains, 2 and 13, still exist and these are not widely used,. The Guinea Pig, because of its large size and caging requirements, is not as widely used as the other laboratory species but does lend itself as an animal model to many research studies. When selecting a particular inbred or many research studies. When selecting a particular inbred or random bred strain of Guinea Pig for utilization, the availability and source should be closely considered. Because of its limited use, only a small number of breeders supply Guinea Pigs. The investigator is encouraged to investigate fully the suggested commercial sources before utilizing the animals these sources. As the quality of the animal received and supplied may vary greatly from one supplier to another, once a particular strain and supplier is selected they should be utilized throughout the entire study. Strain differences between individual breeders may be considerable. Therefore one supplier should be used if possible.

PHYSIOLOGICAL AND GENERAL DATA

Breeding season no definite season
Estrous cycle 16 ½ days (range of 16 to 19 days)
Estrous duration 6 to 11 hours
Gestation period 63 days (range of 59 to 72)
Birth weight 70 - 100 grams 
Litter size 2 to 5
Weaning weight 150-200 grams (14-21 days)
Male breeding age 3 to 4 months
Female breeding age 2 to 3 months
Adult Male weight 1000 to 1200 grams
Adult female weight 850 to 900 grams
Male reproductive life span 4 years
Female reproductive life span 1.5 to 4 years (4-5 litters)
Body temperature 39.1'C (range of 38.4 to 39.8)
Diploid number 64
Respiration rate 90 per minute
Food consumption 6 grams of feed/100 grams of body weight/day
Water consumption 10 ml/100 grams of body weight/day
GI transit time 13-30 hours
Heart rate 280 (range 260 to 400)
 

Guinea Pig
Updated 11/21/2001

ANESTHETIC, ANALGESIC

   Back to Top

ACETAMINOPHEN (TYLENOL)

269 MG/KG IP *7

NONSTEROIDAL ANTI-INFLAMMATORY

ACETHYLSALICYLICATE ACID (ASPIRIN)

269 IP/300 PO/20 SC MG/KG

NONSTEROIDAL ANTI-INFLAMMATORY

ACETYLPROMAZINE (ACEPROMAZINE) - DOSAGE

1-2 MG/KG IM

TRANQUILIZER-PHENOTHIAZINE

BUPIVACAINE (MARCAINE)

AS NEEDED

LOCAL ANESTHETIC

BUPRENORPHINE (BUPRENEX)

0.05 MG/KG SC* Q8-12H**/****

NARCOTIC AGONIST-ANTAGONIST V

CHLORAL HYDRATE 5%

200-400 MG/KG IP

HYPNOTIC

DIAZAPAM (VALIUM) DOSAGE

2.5 MG/KG IP *

TRANQUILIZER - BENZODIAZEPINE IV

DIAZAPAM - DURATION TO EFFECT

1-2 HOURS

TRANQUILIZER - BENZODIAZEPINE IV

DIAZAPAM - TIME TO EFFECT

2-5/5 MIN

TRANQUILIZER - BENZODIAZEPINE IV

DOXAPRAM -DOPRAM V-DOSAGE

5MG/KG IV***

ANALEPTIC

FENTANYL/DROPERIDOL (INNOVAR-VET)-DOSAGE

0.66-0.88 ML/KG IM * (CAUTION)

NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE TRANQUILIZER II

FENTANYL/DROPERDOL - DURATION EFFECT

20-40 MIN

NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE TRANQUILIZER II

FENTANYL/DROPERIDOL - TIME TO EFFECT

15/5 MIN

NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE TRANQUILIZER II

FENTANYL/DROPERIDOL/DIAZEPAM-DOSE

1 ML/KG IM/2.5 MG/KG IP *

NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE TRANQUILIZER,BUTYROPHENONE II

KETAMINE (KETASET, VETALAR) - DOSAGE

50-200 MG/KG IM *

DISSOCIATIVE

KETAMINE-ACEPROMAZINE

125/5 MG/KG IM*/**

DISSOCIATIVE/TRANQUILIZER

KETAMINE-XYLAZINE (ROMPUN)

40-100 IM/4-5 SC IM MG/KG/ OR 87/13 MG/KG IM*

DISSOCIATIVE/ANALGESIC

KETAMINE-DIAZEPAM (VALIUM)

100/5 MG/KG IM*/**

DISSOCIATIVE/TRANQUILIZER

MEPERIDINE (DEMEROL)

20 MG/KG IPIMSC Q2-3H

NARCOTIC II

METHOHEXITAL (BREVITAL/BREVANE)

31 MG/KG IP **

ULTRA SHORT BARBITUATE IV

MORPHINE

10 MG/KG IM SC * Q2-4H **

NARCOTIC II

PENTAZOCINE (TALWIN-V)

10 MG/KG SC IM IV

NON-NARCOTIC ANALGESIC IV

PENTOBARBITAL Na (NEMBUTAL)

35-40 MG/KG IM IP*

BARBITUATE SHORT II

PHENCYCLADINE - DOSAGE

3 MG/KG IM

TRANQUILIZER

PHENCYCLADINE - DURATION

20-60 MIN

TRANQUILIZER

PHENCYCLADINE - TIME EFFECT

5-10 MIN

TRANQUILIZER

PHENCYLADINE - TIME FULL RECOVERY

2 HOURS

TRANQUILIZER

PHENYLBUTAZONE (BUTAZOLDIN)

150 MG/KG IP *7

NONSTEROIDAL ANTI-INFLAMMATORY

THIAMYLAL (SURITAL)

20-50 MG/KG IV,IP

BARBITUATE ULTRASHORT III

THIOPENTAL (PENTOTHAL)

20-55 MG/KG IV IP // 20 IV ****

BARBITUATE ULTRASHORT III

XYLAZINE (ROMPUN)- DOSAGE

3-5 MG/KG IM

ALPHA-2-ADRENERGIC AGONIST SEDATIVE, ANAGESIC, MUSCLE RELAXANT

ANESTHETIC GAS

    Back to Top

HALOTHANE - MAC

0.95

INHALANT

ISOFLURANE - MAC

 

INHALANT

METHOXYFLURANE - MAC

0.22

INHALANT

NITROUS OXIDE-MAC

150

INHALANT

ANTI-INFLAMMATORY

    Back to Top

DEXAMETHASONE (AZIUM)

0.06 MG SC IM IV IP

STEROID

PREDNISONE (METICORTIN)

0.05-0.22 MG SC IM

STEROID

ANTIBIOTIC

    Back to Top

AMOXICILLIN

TOXIC**

ANTIBIOTIC

AMPICILLIN (POLYFLEX)

TOXIC**/***

BETA LACTAM ANTIBIOTIC

BACITRACIN

NEVER

ANTIBIOTIC

CEPHALORIDINE (LORIDINE)

25 MG/KG IM Q24H**/***

BETA LACTAM ANTIBIOTIC

CHLORAMPHENICOL PALMITATE (CHLOROMYCETIN)

50 MMG/KG PO TID ***

BACTERIAL STATIC BROAD SPEC.

CHLORAMPHENICOL SUCCINATE (CHLOROMYCETIN)

20 MG/KG IM Q24H **/***

BACTERIAL STATIC BROAD SPEC.

ERYTHROMYCIN

NEVER

BACTERIAL

GENTAMICIN (GENTOCIN)

5 MG/KG SC IM SID *** 14D*

AMINOGLYCOSIDES

GRISEOFULVIN (FULVICIN U/F)

25 MG/KG PO IN FOOD ***

ANTIFUNGAL

NEOMYCIN (BIOSOL)

10 PO/ 30 SC MG/KG Q24H **// OR 5 PO Q12H/30 SC Q24H MG/KG ***

DIARRHEA

OXYTETRACYCLINE (LIQUAMYCIN)

TOXIC **/***

BACTERIAL STATIC BROAD SPEC.

PENICILLIN

NEVER

ANITBIOTIC

PENICILLIN - BENZATHIN/PROCAINE(BICILLIN)(FLOCILLIN)

BACTERIAL

STREPTOMYCIN (BIOTEC)

NEVER

BACTERIAL

SULFAMETHAZINE OR SULFAMERAZINE

DW 1 MG/ML ***

BACT. COCCIDIA,CIT,B

SULFAQUINOXALINE (SULQUIN)

DW 1 MG/ML ***

EIMERIA,KLOS. PAST.

TETRACYCLINES

TOXIC ***

BACTERIAL STATIC BROAD SPEC//FROG RED LEG

TRIMETHOPRIM (40MG/ML)/SULPHADOXINE (200MG/ML) (TRIBRISSEN)

0.5ML/KG SC**// OR 30 MG/KG SC Q24H (YOUNG 15 MG/KG SC Q24H)***

TRIMETHOPRIM / SULPHONAMIDE

TYLOSIN

66 MG/L 21D

MACROLIDES

ANTICHOLINERGIC

    Back to Top

ATROPINE - DOSAGE

0.05 MG/KG SC IM**/***

ANTICHOLINERGIC

ATROPINE - DURATION EFFECT

15 MIN

ANTICHOLINERGIC

ATROPINE - TIME TO EFFECT

10 MIN

ANTICHOLINERGIC

ANTIPARASITIC

    Back to Top

CARBARYL POWDER (DIRYL)

5 D

ECTOPARASITIC

DICHLORVOS (TASK)

500 MG/KG IN FEED/24H

ECTOPARASITIC-SYPH, HETER

DICHLORVOS (VOPONA STRIPS)

STRIP 48H/WK // OR 1/5 OVER CAGE FOR 3D***

ECTOPARASITIC

FURANACE

NEVER

BACTERIAL

IVERMECTIN (IVOMEC)

200 MCG/KG PO SC***

ANTI-NEMATODES/ECTOPARASITIC

MEBENDAZOLE (TELMIN)

10 MG/KG PO 5D***

NEMATODIASIS COSMOCE

NICLOSAMIDE (YOMESAN)

100 MG/KG PO***

CESTODES-HYMENOLEPSIS

PIPERAZINE

100 MG/KG PO***//3 MG/ML IN WATER + SYRUP *9

ANTI-NEMATODES-SYPHACIA & HET & PINWORMS

SUCCINYSULFATHIAZOLE

1% IN WATER

EIMERIA

THIABENDAZOLE (TBZ; OMIZOLE)

100 MG/KG PO 5D***

ANTI-NEMATODES - OPHIDAS

HORMONE

    Back to Top

OXYTOCIN

0.2-3 UNITS/KG SC IM *9

UTERINE/MILK HORM.

     

EUTHANASIA

Dose Comments  Back to Top

Sodium pentobarbital

150 mg/kg IP Controlled substance
Halothane To effect High Concentration, Rapid flow
Isoflurane To effect High Concentration, Rapid flow

CO2

To effect Requires some other method to ensure death
CO To effect See hazards under euthanasia training

 Potassium chloride

 1-2 mmol/kg IV IC Requires general anesthesia

Cervical dislocation

Unacceptable Too much musculature
Decapitation  Conditionally acceptable Requires scientific justification by user and approval of IACUC, Requires special training and monitoring, Hazard, requires special training for hazard, Equipment has to be maintained. Only on very young.
Chloral hydrate Unacceptable  Not used in Guinea Pigs

Notes

    Back to Top

*= Anesthesia and Analgesia in Laboratory Animals: American College of Laboratory Animal Medicine: 1990
** = Laboratory Animal Anesthesia: Flecknell: 1989
*** = Drug Dosages for Small Mammals: McKellar: 1989
****= Recognition and Alleviation of Pain and Distress in Laboratory Animals: NRC: 1992
*5= Current Veterinary Therapy 2 Food Animal Practice
*6 = University of Calif., San Fran., Morrish
*7 = Basic Care of Experimental Animals
*8= Therapeutic Guide and Anesthesia, O'Harndley
*9= The Biology and Medicine of Rabbits and Rodents
*10= ???????? Continuing Education Vol. 5, No. 4, April 1992
*11 = USUHS Formulary
*12 = LAB ANIMAL OCT 91 PAGE 34
*13= ANESTHESIA AND ANALGESIC DOSES, SCHAEFFER, KNOXVILLE, TN

 




Gateways For: